315 (PB095) - Cisplatin resistance of TMEM16A overexpressing head and neck tumors and cancer models is driven by increased lysosomal flux and reversed by Hydroxychloroquine.
Saved in:
| Title: | 315 (PB095) - Cisplatin resistance of TMEM16A overexpressing head and neck tumors and cancer models is driven by increased lysosomal flux and reversed by Hydroxychloroquine. |
|---|---|
| Authors: | Vyas, A.1 (AUTHOR), Cruz-Rangel, S.1 (AUTHOR), Pacheco, J.1 (AUTHOR), Hammond, G.2 (AUTHOR), Kiselyov, K.3 (AUTHOR), Duvvuri, U.1 (AUTHOR) |
| Source: | European Journal of Cancer. 2022 Supplement 1, Vol. 174, pS112-S112. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/S0959-8049(22)01099-1 |
